Need help finding what you are looking for?
Contact Us
PUBLISHER: Visiongain | PRODUCT CODE: 2151267
PUBLISHER: Visiongain | PRODUCT CODE: 2151267
Global Clinical Trial Supply and Logistics Market 2026-2036
PUBLISHED:
PAGES: 374 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global clinical trial supply and logistics market is valued at US$7.92bn in 2026 and is forecast to reach US$18.22bn by 2036, at a CAGR of 8.7% over the forecast period.
This growth is driven by rising trial complexity across biologics, cell and gene therapies, and precision medicine, the rapid expansion of decentralised and hybrid trial models, and growing globalisation of clinical research into emerging markets requiring integrated regional supply partners.
Technological Innovation Driving Market Expansion
The growing share of biologics, advanced therapies, and personalised medicines in pharma pipelines is creating stronger demand for temperature-controlled clinical logistics. Unlike traditional small molecules, these products require strict cold-chain handling across 2 to 8 degrees Celsius, frozen, ultra-frozen, or cryogenic conditions, where any deviation can compromise product stability, patient safety, and trial validity.
In response, CROs and specialist logistics providers are expanding cryoshipper fleets, digital orchestration platforms, and end-to-end monitoring capabilities to strengthen traceability and maintain product integrity across global clinical supply chains. Real-time temperature monitoring, validated packaging, qualified storage, and robust contingency planning are becoming standard requirements rather than premium services.
On 10 June 2026, X-Therma commercially launched its XT-NoVo and TimeSeal platform, an end-to-end biopreservation solution enabling ice-free, DMSO-free sub-zero preservation and transportation of high-value biologics. This helps extend product viability while supporting more reliable cold-chain logistics for advanced therapies across clinical supply networks globally.
Trade, Policy & Supply Chain Dynamics
- U.S. trade tariffs could increase the operating cost and planning complexity of global clinical trial supply chains, particularly where investigational medicinal products, comparators, packaging materials, temperature-controlled containers, and laboratory kits move across borders.
- The impact would be strongest for multi-country trials involving frequent cross-border shipments between the U.S., Europe, China, India, and other major pharma hubs, where even modest cost increases can affect depot strategy and sponsor budgets.
- Sponsors may need to reassess sourcing locations, use regional depots more actively, and hold higher safety stock to reduce exposure to customs delays or cost volatility.
- Tariffs are unlikely to reduce clinical trial activity materially, as drug development timelines and regulatory commitments remain critical. The market impact is expected to be operational rather than demand-destructive, encouraging greater regionalisation and more resilient clinical supply models.
Commercial Impact
- Cost pressure: Tariffs on pharmaceutical inputs, laboratory equipment, packaging components, and specialised logistics materials are indirectly raising operational costs throughout the clinical supply chain
- Supply chain shifts: Sponsors are placing greater emphasis on supply chain diversification, regional sourcing, and localised inventory management to minimise cross-border exposure and customs risk
- Depot strategy: Logistics providers are expanding regional depot networks, strengthening customs and trade compliance capabilities, and optimising distribution routes to maintain reliable trial operations
- Competitive positioning: Providers with strong trade compliance, bonded warehousing, and regional distribution networks are better positioned to support sponsors navigating a more complex cost and customs environment
Company Intelligence
The clinical trial supply and logistics market is characterised by a mix of global CROs, specialist clinical supply organisations, integrated logistics providers, and CDMO-adjacent companies competing across cold-chain capability, depot network scale, and end-to-end service integration.
Leading companies including Thermo Fisher Scientific, IQVIA, Almac Group, PCI Pharma Services, and World Courier are strengthening their positions through capacity investment, digital platform development, and expansion of direct-to-patient and regional supply capabilities.
Competition is increasingly defined by:
- Cold-chain infrastructure and cryogenic logistics capability for advanced therapy programmes
- Direct-to-patient fulfilment and home healthcare coordination capability
- Regional depot network depth and customs compliance expertise across emerging markets
- Digital integration across forecasting, chain-of-custody visibility, and real-time temperature monitoring
This report analyses how competitive positioning is evolving across 23 leading companies, identifying where value is being created and how strategies are expected to shift over the forecast period.
Key Questions Answered
- What is the projected size of the clinical trial supply and logistics market by 2036?
- Which segments and regions will drive growth?
- How will decentralised trial models and cold-chain complexity shape the competitive landscape?
- What is the impact of U.S. trade tariffs on cross-border supply chain operations?
- Who are the leading companies and how will their positions evolve?
Report Scope and Data Coverage
- Global clinical trial supply and logistics market analysis
- Revenue forecasts to 2036
- Segment-level modelling across type, phase, temperature, and therapeutic area
- Regional and national market forecasts across five regions and 26 leading national markets
- Competitive intelligence on 23 leading companies
Includes both quantitative forecasting and qualitative strategic analysis, covering technology, competition, policy, and supply chain dynamics.
Segmentation Framework
By Type
- CTS Manufacturing
- CTS Logistics & Distribution
- CT Supply Chain Management
- CTS Packaging & Storage
By Phase
- Preclinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Post Launch
By Temperature
- Ambient (15 to 25°C)
- Refrigerated (2 to 8°C)
- Frozen (0 to -20°C)
- Cryogenic (-20 to -150°C)
By Therapeutic Area
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Dermatology
- Ophthalmology
- Other Therapeutic Areas
Geographic Coverage
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- South-East Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Company Intelligence Coverage
This report includes detailed profiles of 23 leading companies, including:
- Almac Group
- Biocair
- Catalent, Inc.
- Charles River
- Clinigen Limited
- DHL Health Logistics
- Eurofins Scientific
- Fortrea
- ICON plc
- IQVIA Inc.
- Kuehne+Nagel
- Labcorp
- Marken (UPS Healthcare)
- Medpace
- Movianto
- Myonex
- Oximio
- Parexel International Corporation
- PCI Pharma Services (PCI)
- Pharmaron
- Sharp Services LLC
- Syneos Health
- Thermo Fisher Scientific Inc.
- World Courier (Cencora)
- WuXi AppTec
Each profile includes:
- Business overview
- Financial and market positioning
- Product and technology capabilities
- Strategic outlook
Bespoke Intelligence & Customisation
Visiongain also provides tailored intelligence and advisory support aligned to specific client requirements.
This includes:
- Custom market segmentation and forecasts
- Competitive benchmarking and strategy analysis
- Policy and regulatory impact assessment
- Supply chain and sourcing intelligence
- Scenario modelling including tariffs, and geopolitical risk
Why This Market Intelligence Matters
- The clinical trial supply and logistics market is evolving rapidly, driven by rising trial complexity, cold-chain demand growth, and the expanding adoption of decentralised and direct-to-patient delivery models.
- Organisations that understand these dynamics will be better positioned to capture high-value outsourcing opportunities, manage operational risk, and strengthen competitive positioning.
- Purchase the Clinical Trial Supply and Logistics Market for Pharma 2026-2036 to access the complete dataset, forecasts, and competitive analysis.
Product Code: PHA1395
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report Include:
- 1.6 Who is This Report For?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.3 Impact Analysis
- 3.3.1 Market Driving Factors
- 3.3.1.1 Growth in Biologics and Gene Therapies
- 3.3.1.2 Growing Demand for Cold Chain Temperature Controlled Logistics
- 3.3.1.3 Rise in Outsourcing of Trial Supply Functions
- 3.3.1.4 Move Towards Decentralised / Virtual Clinical Trials
- 3.3.1.5 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
- 3.3.1.6 Increasing Adoption of Integrated Clinical Trial Supply Management Solutions
- 3.3.2 Market Restraining Factors
- 3.3.2.1 Clinical Trial and Medical Cold Chain Logistics
- 3.3.2.2 Man-made or Natural Disruption in Transportation
- 3.3.3 Market Opportunities
- 3.3.3.1 AI and Machine Learning are Evolving with More Data
- 3.3.3.3 Big Companies are Driving the Market
- 3.3.1 Market Driving Factors
- 3.4 U.S. Tariffs: What's the Impact on Global Clinical Trial Supply and Logistics for Pharma Market?
- 3.4.1 Overview
- 3.4.2 V-Shaped Recovery Scenario
- 3.4.3 Why V-Shaped Recovery?
- 3.4.3.1 Impact from Tariffs
- 3.4.3.2 Market Dynamics and Demand Recovery
- 3.4.3.3 Policy and Funding Support
- 3.4.3.4 Timeframe for Recovery
- 3.4.4 U-Shaped Recovery Scenario
- 3.4.4.1 Why U-Shaped Recovery?
- 3.4.4.2 Impact from Tariffs
- 3.4.4.3 Market Dynamics and Demand Recovery
- 3.4.4.4 Policy and Funding Support
- 3.4.4.5 Timeframe for Recovery
- 3.4.5 L Shaped Recovery Scenario
- 3.4.5.1 Why L-Shaped Recovery?
- 3.4.5.2 Impact from Tariffs
- 3.4.5.3 Market Dynamics and Demand Recovery
- 3.4.5.4 Policy and Funding Support
- 3.4.5.5 Timeframe for Recovery
- 3.4.6 What Strategic Considerations Should Clients Factor into Their Near-term (2026-2031) and Long-term (2026-2036) Planning?
- 3.4.7 Impact of U.S. and China Trade War on Clinical Trial Supply and Logistics for Pharma Market
- 3.4.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
- 3.5 Porter's Five Forces Analysis
- 3.5.1 Bargaining Power of Suppliers
- 3.5.2 Bargaining Power of Buyers
- 3.5.3 Competitive Rivalry
- 3.5.4 Threat from Substitutes
- 3.5.5 Threat of New Entrants
- 3.6 PEST Analysis
4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type
- 4.1 Key Findings
- 4.2 Type Segment: Market Attractiveness Index
- 4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 4.4 CTS Manufacturing
- 4.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 4.4.2 Market Share by Region, 2026 & 2036 (%)
- 4.5 CTS Logistics & Distribution
- 4.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 4.5.2 Market Share by Region, 2026 & 2036 (%)
- 4.6 CT Supply Chain Management
- 4.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 4.6.2 Market Share by Region, 2026 & 2036 (%)
- 4.7 CTS Packaging & Storage
- 4.7.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 4.7.2 Market Share by Region, 2026 & 2036 (%)
5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase
- 5.1 Key Findings
- 5.2 Phase Segment: Market Attractiveness Index
- 5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 5.4 Preclinical
- 5.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 5.4.2 Market Share by Region, 2026 & 2036 (%)
- 5.5 Phase I
- 5.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 5.5.2 Market Share by Region, 2026 & 2036 (%)
- 5.6 Phase II
- 5.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 5.6.2 Market Share by Region, 2026 & 2036 (%)
- 5.7 Phase III
- 5.7.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 5.7.2 Market Share by Region, 2026 & 2036 (%)
- 5.8 Phase IV
- 5.8.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 5.8.2 Market Share by Region, 2026 & 2036 (%)
- 5.9 Post Launch
- 5.9.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 5.9.2 Market Share by Region, 2026 & 2036 (%)
6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Temperature
- 6.1 Key Findings
- 6.2 Temperature Segment: Market Attractiveness Index
- 6.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
- 6.4 Ambient (15 - 25°C)
- 6.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 6.4.2 Market Share by Region, 2026 & 2036 (%)
- 6.5 Refrigerated (2 - 8°C)
- 6.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 6.5.2 Market Share by Region, 2026 & 2036 (%)
- 6.6 Frozen (0 - -20°C)
- 6.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 6.6.2 Market Share by Region, 2026 & 2036 (%)
- 6.7 Cryogenic (-20 - -150°C)
- 6.7.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 6.7.2 Market Share by Region, 2026 & 2036 (%)
7 Clinical Trial Supply and Logistics for Pharma Market Analysis by Therapeutic Area
- 7.1 Key Findings
- 7.2 Therapeutic Area Segment: Market Attractiveness Index
- 7.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
- 7.4 Oncology
- 7.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.4.2 Market Share by Region, 2026 & 2036 (%)
- 7.5 Infectious Diseases
- 7.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.5.2 Market Share by Region, 2026 & 2036 (%)
- 7.6 Cardiovascular Diseases
- 7.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.6.2 Market Share by Region, 2026 & 2036 (%)
- 7.7 Autoimmune Diseases
- 7.7.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.7.2 Market Share by Region, 2026 & 2036 (%)
- 7.8 Dermatology
- 7.8.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.8.2 Market Share by Region, 2026 & 2036 (%)
- 7.9 Ophthalmology
- 7.9.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.9.2 Market Share by Region, 2026 & 2036 (%)
- 7.10 Other Therapeutic Areas
- 7.10.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- 7.10.2 Market Share by Region, 2026 & 2036 (%)
8 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region
- 8.1 Key Findings
- 8.2 Regional Market Size Estimation and Forecast
9 North America Clinical Trial Supply and Logistics for Pharma Market Analysis
- 9.1 Key Findings
- 9.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- 9.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 9.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
- 9.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 9.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 9.7 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
- 9.8 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
- 9.9 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
- 9.10 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis
10 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.1 Key Findings
- 10.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- 10.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 10.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
- 10.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 10.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 10.7 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
- 10.8 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
- 10.9 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.10 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.11 France Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.12 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.13 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.14 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.15 Netherlands Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.16 Switzerland Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.17 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
11 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11.1 Key Findings
- 11.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- 11.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 11.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
- 11.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 11.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 11.7 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
- 11.8 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
- 11.9 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11.10 China Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11.11 India Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11.12 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11.13 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11.14 South East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11.15 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
12 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
- 12.1 Key Findings
- 12.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- 12.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 12.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
- 12.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 12.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 12.7 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
- 12.8 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
- 12.9 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
- 12.10 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
- 12.11 Argentina Clinical Trial Supply and Logistics for Pharma Market Analysis
- 12.12 Colombia Clinical Trial Supply and Logistics for Pharma Market Analysis
- 12.13 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
13 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
- 13.1 Key Findings
- 13.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- 13.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 13.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
- 13.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 13.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 13.7 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
- 13.8 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
- 13.9 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
- 13.10 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
- 13.11 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
14 Company Profiles
- 14.1 Catalent, Inc.
- 14.1.1 Company Snapshot
- 14.1.2 Company Overview
- 14.1.3 Financial Analysis
- 14.1.3.1 Net Revenue, 2022-2024
- 14.1.3.2 Regional Market Shares, 2024
- 14.1.4 Service Benchmarking
- 14.1.5 Strategic Outlook
- 14.2 Biocair
- 14.2.1 Company Snapshot
- 14.2.2 Company Overview
- 14.2.3 Financial Analysis
- 14.2.4 Service Benchmarking
- 14.2.5 Strategic Outlook
- 14.3 DHL - Life Sciences & Healthcare (DHL Health Logistics)
- 14.3.1 Company Snapshot
- 14.3.2 Company Overview
- 14.3.3 Financial Analysis
- 14.3.3.1 Net Revenue, 2022-2024
- 14.3.3.2 Regional Market Shares, 2025
- 14.3.4 Service Benchmarking
- 14.3.5 Strategic Outlook
- 14.4 Marken ( a clinical logistics subsidiary of UPS Healthcare Precision Logistics)
- 14.4.1 Company Snapshot
- 14.4.2 Company Overview
- 14.4.3 Financial Analysis
- 14.4.3.1 Net Revenue, 2022-2025
- 14.4.4 Service Benchmarking
- 14.4.5 Strategic Outlook
- 14.5 Movianto
- 14.5.1 Company Snapshot
- 14.5.2 Company Overview
- 14.5.3 Financial Analysis
- 14.5.4 Service Benchmarking
- 14.5.5 Strategic Outlook
- 14.6 Thermo Fisher Scientific Inc. (PPD)
- 14.6.1 Company Snapshot
- 14.6.2 Company Overview
- 14.6.3 Financial Analysis
- 14.6.3.1 Net Revenue, 2020-2024
- 14.6.3.2 R&D, 2020-2024
- 14.6.3.3 Regional Market Shares, 2024
- 14.6.3.4 Business Segment Market Shares, 2024
- 14.6.4 Service Benchmarking
- 14.6.5 Strategic Outlook
- 14.7 ICON plc
- 14.7.1 Company Snapshot
- 14.7.2 Company Overview
- 14.7.3 Financial Analysis
- 14.7.3.1 Revenue, 2020-2024
- 14.7.3.2 Regional Market Shares, 2025
- 14.7.4 Service Benchmarking
- 14.7.5 Strategic Outlook
- 14.8 Eurofins Scientific
- 14.8.1 Company Snapshot
- 14.8.2 Company Overview
- 14.8.3 Financial Analysis
- 14.8.3.1 Net Revenue, 2022-2025
- 14.8.3.2 Regional Market Shares, 2025
- 14.8.3.3 Business Segment Market Shares, 2025
- 14.8.4 Services Offered
- 14.8.5 Strategic Outlook
- 14.9 Almac Group
- 14.9.1 Company Snapshot
- 14.9.2 Company Overview
- 14.9.3 Service Benchmarking
- 14.9.4 Strategic Outlook
- 14.10 Parexel International Corporation
- 14.10.1 Company Snapshot
- 14.10.2 Company Overview
- 14.10.3 Service Benchmarking
- 14.10.4 Strategic Outlook
- 14.11 PCI Pharma Services (PCI)
- 14.11.1 Company Snapshot
- 14.11.2 Company Overview
- 14.11.3 Service Benchmarking
- 14.11.4 Strategic Outlook
- 14.12 IQVIA Inc.
- 14.12.1 Company Snapshot
- 14.12.2 Company Overview
- 14.12.3 Financial Analysis
- 14.12.3.1 Net Revenue, 2022-2025
- 14.12.3.2 Regional Market Shares, 2025
- 14.12.3.3 Business Segment Market Shares, 2025
- 14.12.4 Service Benchmarking
- 14.12.5 Strategic Outlook
- 14.13 WuXi AppTec
- 14.13.1 Company Snapshot
- 14.13.2 Company Overview
- 14.13.3 Financial Analysis
- 14.13.3.1 Net Revenue, 2022-2025
- 14.13.3.2 Regional Market Shares, 2025
- 14.13.3.3 Business Segment Market Shares, 2025
- 14.13.4 Service Benchmarking
- 14.13.5 Strategic Outlook
- 14.14 Charles River Laboratories
- 14.14.1 Company Snapshot
- 14.14.2 Company Overview
- 14.14.3 Financial Analysis
- 14.14.3.1 Net Revenue, 2022-2025
- 14.14.3.2 Regional Market Shares, 2025
- 14.14.3.3 Business Segment Market Shares, 2025
- 14.14.4 Service Benchmarking
- 14.14.5 Strategic Outlook
- 14.15 Pharmaron
- 14.15.1 Company Snapshot
- 14.15.2 Company Overview
- 14.15.3 Financial Analysis
- 14.15.3.1 Net Revenue, 2022-2025
- 14.15.3.2 Regional Market Shares, 2025
- 14.15.3.3 Business Segment Market Shares, 2025
- 14.15.4 Service Benchmarking
- 14.16 Fortrea
- 14.16.1 Company Snapshot
- 14.16.2 Company Overview
- 14.16.3 Financial Analysis
- 14.16.3.1 Net Revenue, 2022-2025
- 14.16.3.2 Regional Market Shares, 2025
- 14.16.4 Service Benchmarking
- 14.16.5 Strategic Outlook
- 14.17 Medpace
- 14.17.1 Company Snapshot
- 14.17.2 Company Overview
- 14.17.3 Financial Analysis
- 14.17.3.1 Net Revenue, 2022-2025
- 14.17.3.2 Business Segment Market Shares, 2025
- 14.17.4 Service Benchmarking
- 14.18 Sharp Services, LLC
- 14.18.1 Company Snapshot
- 14.18.2 Company Overview
- 14.18.3 Financial Analysis
- 14.18.3.1 Net Revenue, 2022-2024
- 14.18.4 Service Benchmarking
- 14.18.5 Strategic Outlook
- 14.19 Clinigen Limited
- 14.19.1 Company Snapshot
- 14.19.2 Company Overview
- 14.19.3 Service Benchmarking
- 14.19.4 Strategic Outlook
- 14.20 Syneos Health
- 14.20.1 Company Snapshot
- 14.20.2 Company Overview
- 14.20.3 Service Benchmarking
- 14.21 Labcorp
- 14.21.1 Company Snapshot
- 14.21.2 Company Overview
- 14.21.3 Financial Analysis
- 14.21.3.1 Net Revenue, 2022-2025
- 14.21.3.2 Regional Market Shares, 2025
- 14.21.3.3 Business Segment Market Shares, 2025
- 14.21.4 Service Benchmarking
- 14.21.5 Strategic Outlook
- 14.22 Myonex
- 14.22.1 Company Snapshot
- 14.22.2 Company Overview
- 14.22.3 Service Benchmarking
- 14.22.4 Strategic Outlook
- 14.23 World Courier (Cencora)
- 14.23.1 Company Snapshot
- 14.23.2 Company Overview
- 14.23.3 Financial Analysis
- 14.23.3.1 Net Revenue, 2022-2025
- 14.23.4 Service Benchmarking
- 14.23.5 Strategic Outlook
15 Conclusion and Recommendations
- 15.1 Concluding Remarks from Visiongain
- 15.2 Recommendations for Market Players
Product Code: PHA1395
List of Tables
- Table 1 Clinical Trial Supply and Logistics for Pharma Market Snapshot, 2026 & 2036 (US$ Billion, CAGR %)
- Table 2 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %): "V" Shaped Recovery
- Table 3 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %): "U" Shaped Recovery
- Table 4 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %): "L" Shaped Recovery
- Table 5 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 6 CTS Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 7 CTS Logistics & Distribution Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 8 CT Supply Chain Management Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 9 CTS Packaging & Storage Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 10 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 11 Preclinical Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 12 Phase I Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 13 Phase II Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 14 Phase III Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 15 Phase IV Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 16 Post Launch Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 17 Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 18 Ambient (15 - 25°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 19 Refrigerated (2 - 8°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 20 Frozen (0 - -20°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 21 Cryogenic (-20 - -150°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 22 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 23 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 24 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 25 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 26 Autoimmune Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 27 Dermatology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 28 Ophthalmology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 29 Other Therapeutic Areas Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 30 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 31 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 32 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 33 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 34 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 35 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 36 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 37 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 38 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 39 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 40 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 41 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 42 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 43 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 44 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 45 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 46 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 47 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 48 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 49 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 50 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 51 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 52 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 53 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 54 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 55 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 56 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 57 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 58 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 59 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 60 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 61 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 62 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 63 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 64 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 65 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 66 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 67 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 68 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 69 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 70 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 71 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 72 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 73 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 74 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 75 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 76 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 77 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 78 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 79 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 80 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 81 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
- Table 82 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 83 Catalent, Inc.: Service Benchmarking
- Table 84 Catalent, Inc.: Strategic Outlook
- Table 85 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 86 Biocair .: Service Benchmarking
- Table 87 Biocair.: Strategic Outlook
- Table 88 DHL - Life Sciences & Healthcare (DHL Health Logistics): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 89 DHL - Life Sciences & Healthcare (DHL Health Logistics): Service Benchmarking
- Table 90 DHL - Life Sciences & Healthcare (DHL Health Logistics): Strategic Outlook
- Table 91 Marken (a clinical logistics subsidiary of UPS Healthcare Precision Logistics): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 92 Marken (a clinical logistics subsidiary of UPS Healthcare Precision Logistics): Service Benchmarking
- Table 93 Marken (a subsidiary of UPS Healthcare Precision Logistics): Strategic Outlook
- Table 94 Movianto: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 95 Movianto: Service Benchmarking
- Table 96 Marken (a subsidiary of UPS Healthcare Precision Logistics): Strategic Outlook
- Table 97 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 98 Thermo Fisher Scientific Inc.: Service Benchmarking
- Table 99 Thermo Fisher Scientific Inc.: Strategic Outlook
- Table 100 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 101 ICON plc: Service Benchmarking
- Table 102 ICON plc: Strategic Outlook
- Table 103 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 104 Eurofins Scientific: Services Offered
- Table 105 Eurofins Scientific: Strategic Outlook
- Table 106 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 107 Almac Group: Service Benchmarking
- Table 108 Almac Group: Strategic Outlook
- Table 109 Parexel International Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 110 Parexel International Corporation: Service Benchmarking
- Table 111 Parexel International Corporation: Strategic Outlook
- Table 112 PCI Pharma Services (PCI): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 113 PCI Pharma Services (PCI): Service Benchmarking
- Table 114 PCI Pharma Services (PCI): Strategic Outlook
- Table 115 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 116 IQVIA Inc.: Service Benchmarking
- Table 117 IQVIA Inc.: Strategic Outlook
- Table 118 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 119 WuXi AppTec: Service Benchmarking
- Table 120 WuXi AppTec: Strategic Outlook
- Table 121 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 122 Charles River Laboratories: Service Benchmarking
- Table 123 Charles River Laboratories: Strategic Outlook
- Table 124 Pharmaron: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 125 Pharmaron: Service Benchmarking
- Table 126 Fortrea: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 127 Fortrea: Service Benchmarking
- Table 128 Fortrea: Strategic Outlook
- Table 129 Medpace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 130 Medpace: Service Benchmarking
- Table 131 Sharp Services, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 132 Sharp Services, LLC: Service Benchmarking
- Table 133 Sharp Services, LLC: Strategic Outlook
- Table 134 Clinigen Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 135 Clinigen Limited: Service Benchmarking
- Table 136 Clinigen Limited: Strategic Outlook
- Table 137 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 138 Syneos Health: Service Benchmarking
- Table 139 Labcorp: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 140 Labcorp: Service Benchmarking
- Table 141 Labcorp: Strategic Outlook
- Table 142 Myonex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 143 Myonex: Service Benchmarking
- Table 144 Myonex: Strategic Outlook
- Table 145 World Courier (Cencora): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 146 World Courier (Cencora): Service Benchmarking
- Table 147 World Courier (Cencora): Strategic Outlook
List of Figures
- Figure 1 Clinical Trial Supply and Logistics for Pharma Market Segmentation
- Figure 2 Clinical Trial Supply and Logistics for Pharma Market by Type: Market Attractiveness Index
- Figure 3 Clinical Trial Supply and Logistics for Pharma Market by Phase: Market Attractiveness Index
- Figure 4 Clinical Trial Supply and Logistics for Pharma Market by Temperature: Market Attractiveness Index
- Figure 5 Clinical Trial Supply and Logistics for Pharma Market by Therapeutic Area: Market Attractiveness Index
- Figure 6 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Region
- Figure 7 Clinical Trial Supply and Logistics for Pharma Market: Market Dynamics
- Figure 8 Clinical Trial Supply and Logistics for Pharma Market: Impact Analysis
- Figure 9 Clinical Trial Supply and Logistics for Pharma Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
- Figure 10 Clinical Trial Supply and Logistics for Pharma Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
- Figure 11 Clinical Trial Supply and Logistics for Pharma Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
- Figure 12 Short Term & Long-Term Planning
- Figure 13 Impact of U.S. and China Trade War
- Figure 14 Most Impacted Countries
- Figure 15 Clinical Trial Supply and Logistics for Pharma Market: Porter's Five Forces Analysis
- Figure 16 Clinical Trial Supply and Logistics for Pharma Market: PEST Analysis
- Figure 17 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
- Figure 18 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- Figure 19 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026, 2031, 2036 (%)
- Figure 20 CTS Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 21 CTS Manufacturing Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 22 CTS Logistics & Distribution Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 23 CTS Logistics & Distribution Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 24 CT Supply Chain Management Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 25 CT Supply Chain Management Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 26 CTS Packaging & Storage Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 27 CTS Packaging & Storage Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 28 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
- Figure 29 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
- Figure 30 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026, 2031, 2036 (%)
- Figure 31 Preclinical Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 32 Preclinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 33 Phase I Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 34 Phase I Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 35 Phase II Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 36 Phase II Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 37 Phase III Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 38 Phase III Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 39 Phase IV Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 40 Phase IV Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 41 Post Launch Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 42 Post Launch Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 43 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Temperature
- Figure 44 Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
- Figure 45 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026, 2031, 2036 (%)
- Figure 46 Ambient (15 - 25°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 47 Ambient (15 - 25°C) Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 48 Refrigerated (2 - 8°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 49 Refrigerated (2 - 8°C) Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 50 Frozen (0 - -20°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 51 Frozen (0 - -20°C) Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 52 Cryogenic (-20 - -150°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 53 Cryogenic (-20 - -150°C) Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 54 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Therapeutic Area
- Figure 55 Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
- Figure 56 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026, 2031, 2036 (%)
- Figure 57 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 58 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 59 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 60 Infectious Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 61 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 62 Cardiovascular Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 63 Autoimmune Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 64 Autoimmune Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 65 Dermatology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 66 Dermatology Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 67 Ophthalmology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 68 Ophthalmology Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 69 Other Therapeutic Areas Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 70 Other Therapeutic Areas Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 71 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region 2026, 2031, 2036 (Revenue, CAGR%)
- Figure 72 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Region 2026, 2031, 2036 (%)
- Figure 73 Clinical Trial Supply and Logistics for Pharma Market by Region, 2026-2036 (US$ Mn)
- Figure 74 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- Figure 75 North America Clinical Trial Supply and Logistics for Pharma Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 76 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 77 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 78 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- Figure 79 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026 & 2036 (%)
- Figure 80 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
- Figure 81 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026 & 2036 (%)
- Figure 82 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
- Figure 83 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026 & 2036 (%)
- Figure 84 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
- Figure 85 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
- Figure 86 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 87 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 88 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- Figure 89 Europe Clinical Trial Supply and Logistics for Pharma Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 90 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 91 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 92 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- Figure 93 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026 & 2036 (%)
- Figure 94 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
- Figure 95 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026 & 2036 (%)
- Figure 96 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
- Figure 97 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026 & 2036 (%)
- Figure 98 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
- Figure 99 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
- Figure 100 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 101 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 102 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 103 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 104 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 105 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 106 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 107 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 108 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 109 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- Figure 110 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 111 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 112 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 113 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- Figure 114 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026 & 2036 (%)
- Figure 115 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
- Figure 116 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026 & 2036 (%)
- Figure 117 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
- Figure 118 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026 & 2036 (%)
- Figure 119 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
- Figure 120 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
- Figure 121 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 122 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 123 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 124 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 125 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 126 South East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 127 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 128 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- Figure 129 Latin America Clinical Trial Supply and Logistics for Pharma Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 130 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 131 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 132 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- Figure 133 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026 & 2036 (%)
- Figure 134 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
- Figure 135 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026 & 2036 (%)
- Figure 136 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
- Figure 137 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026 & 2036 (%)
- Figure 138 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
- Figure 139 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
- Figure 140 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 141 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 142 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 143 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 144 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 145 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- Figure 146 MEA Clinical Trial Supply and Logistics for Pharma Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 147 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 148 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 149 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
- Figure 150 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026 & 2036 (%)
- Figure 151 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
- Figure 152 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026 & 2036 (%)
- Figure 153 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
- Figure 154 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026 & 2036 (%)
- Figure 155 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
- Figure 156 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
- Figure 157 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 158 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 159 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 160 Catalent, Inc.: Net Revenue, 2022-2024 (US$ Million, AGR %)
- Figure 161 Catalent, Inc.: Regional Market Shares, 2024
- Figure 162 DHL - Life Sciences & Healthcare (DHL Health Logistics): Net Revenue, 2022-2024 (US$ Million, AGR %)
- Figure 163 DHL - Life Sciences & Healthcare (DHL Health Logistics): Regional Market Shares, 2025
- Figure 164 Marken (a clinical logistics subsidiary of UPS Healthcare Precision Logistics): Net Revenue, 2022-2025 (US$ Million, AGR %)
- Figure 165 Thermo Fisher Scientific Inc: Net Revenue, 2020-2024 (US$ Million, AGR %)
- Figure 166 Thermo Fisher Scientific Inc: R&D, 2020-2024 (US$ Million, AGR %)
- Figure 167 Thermo Fisher Scientific Inc: Regional Market Shares, 2024
- Figure 168 Thermo Fisher Scientific Inc: Business Segment Market Shares, 2024
- Figure 169 ICON plc: Revenue, 2020-2024 (US$ Million, AGR %)
- Figure 170 ICON plc: Regional Market Shares, 2025
- Figure 171 Eurofins Scientific: Net Revenue, 2022-2025 (US$ Million, AGR %)
- Figure 172 Eurofins Scientific: Regional Market Shares, 2025
- Figure 173 Eurofins Scientific: Business Segment Market Shares, 2025
- Figure 174 IQVIA Inc.: Net Revenue, 2022-2025 (US$ Million, AGR %)
- Figure 175 IQVIA Inc.: Regional Market Shares, 2025
- Figure 176 IQVIA Inc.: Business Segment Market Shares, 2025
- Figure 177 WuXi AppTec: Net Revenue, 2022-2025 (US$ Million, AGR %)
- Figure 178 WuXi AppTec: Regional Market Shares, 2025
- Figure 179 WuXi AppTec: Business Segment Market Shares, 2025
- Figure 180 Charles River Laboratories: Net Revenue, 2022-2025 (US$ Million, AGR %)
- Figure 181 Charles River Laboratories: Regional Market Shares, 2025
- Figure 182 Charles River Laboratories: Business Segment Market Shares, 2025
- Figure 183 Pharmaron: Net Revenue, 2022-2025 (US$ Million, AGR %)
- Figure 184 Pharmaron: Regional Market Shares, 2025
- Figure 185 Pharmaron: Business Segment Market Shares, 2025
- Figure 186 Fortrea: Net Revenue, 2022-2025 (US$ Million, AGR %)
- Figure 187 Fortrea: Regional Market Shares, 2025
- Figure 188 Medpace: Net Revenue, 2022-2025 (US$ Million, AGR %)
- Figure 189 Medpace: Business Segment Market Shares, 2025
- Figure 190 Sharp Services, LLC: Net Revenue, 2022-2024 (US$ Million, AGR %)
- Figure 191 Labcorp: Net Revenue, 2022-2025 (US$ Million, AGR %)
- Figure 192 Labcorp: Regional Market Shares, 2025
- Figure 193 Labcorp: Business Segment Market Shares, 2025
- Figure 194 World Courier (Cencora): Net Revenue, 2022-2025 (US$ Million, AGR %)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.